Meal Strategies for Type 1 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you must not start any new non-insulin glucose-lowering medications during the trial.
What data supports the effectiveness of the treatment Carbohydrate counting, Carb counting, Meal planning, Simple Meal Bolusing, Simple Meal Bolus Strategy, Simplified Meal Boluses for Type 1 Diabetes?
Is carbohydrate counting safe for people with diabetes?
Carbohydrate counting is a widely used meal planning approach for people with diabetes, especially type 1 diabetes, and is considered safe. It helps manage blood sugar levels by focusing on the amount of carbohydrates consumed, and it can be adapted for different insulin regimens, making it flexible and enjoyable for patients.26789
How does the treatment 'Carbohydrate counting and Simple Meal Bolusing' differ from other treatments for Type 1 Diabetes?
Carbohydrate counting and Simple Meal Bolusing is unique because it focuses on counting carbohydrates to manage blood sugar levels, allowing for flexible meal planning and precise insulin dosing. This approach is particularly beneficial for those using insulin pumps or multiple daily injections, as it helps tailor insulin doses to individual meals, unlike traditional fixed-dose insulin regimens.12467
What is the purpose of this trial?
The goal of this trial is to evaluate blood sugar control in patients with type 1 diabetes when using a simple meal bolus strategy (small, medium, large meals) compared to carbohydrate counting when on a hybrid closed loop system. The main question it aims to answer are:What is the blood sugar time in range when using simple meal boluses versus carbohydrate counting?Participants will:Use the simple meal bolus plan for 4 weeks. Do precise carbohydrate counting for 4 weeks. Provide their continuous glucose monitor and pump data Take surveys about the experience of meal bolusing during the study
Eligibility Criteria
This trial is for adolescents with Type 1 Diabetes who have been diagnosed for at least a year and are using a hybrid closed loop system. They should not plan to use new non-insulin glucose-lowering drugs during the study and must be willing to follow all procedures.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Run-in Period
Participants undergo a 2-week run-in period of usual care to establish baseline data and adjust pump settings as needed
Treatment Phase 1
Participants use either the simple meal bolus plan or precise carbohydrate counting for 4 weeks
Wash-out Period
Participants return to usual care for 1 week to wash out the effects of the first treatment phase
Treatment Phase 2
Participants switch to the opposite meal bolus strategy for another 4 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Carbohydrate counting
- Simple Meal Bolusing
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor